JMIR Publications

ABSTRACT

Background:

Alcohol-associated liver disease (ALD) is increasingly common and associated with serious and costly health consequences. Cessation of drinking can improve ALD morbidity and mortality yet support for cessation is not routinely offered to those diagnosed with ALD, and continued drinking or resumption of drinking after diagnosis is common. Mobile health (mHealth) has the potential to offer convenient and scalable support for alcohol cessation to those diagnosed with ALD, but mHealth interventions for alcohol cessation have not been designed for or evaluated in a population with ALD.

Objective:

In this study, we sought to understand how individuals with ALD would perceive and use an mHealth tool for alcohol cessation, and to gather their perspectives on potential refinements to the tool that would allow it to better meet their needs.

Methods:

We interviewed 11 individuals who attended clinic visits related to their ALD to elicit their needs related to support for alcohol cessation, and how mHealth could be applied. After completing initial interviews (pre-), participants were provided with access to an mHealth app designed for alcohol cessation, which they used for one month. Afterwards, they were interviewed again (post-) to give feedback on their experiences, including aspects of the app that met their needs, and potential refinements. We applied a mixed-methods approach, including a qualitative analysis to identify major themes from the interview transcripts, and descriptive analyses of use of the app over one month.

Results:

We found, first, that a diagnosis of ALD is perceived as a motivator to quit drinking, but that patients had difficulty processing the overwhelming amount of information about ALD they received and finding resources for cessation of alcohol use. Second, we found that the app was perceived as usable and useful for supporting drinking recovery, with patients responding favorably to self-tracking and motivational components of the app. Finally, patients identified areas in which the app could be adapted to meet the needs of patients with ALD, such as providing information on the medical implications of an ALD diagnosis and how to care for their liver, as well as connecting individuals with ALD to one another via a peer-to-peer support forum. Rates of app use were high and sustained across the entire study, with participants using the app a little more than half the days during the study on average, and with 100% of participants logging in each week.

Conclusions:

Our results highlight the need for convenient access to resources for alcohol cessation after ALD diagnosis, and support the potential of an mHealth approach to integrate recovery support into care for ALD. Our findings also highlight the ways the alcohol cessation app should be modified to address ALD-specific concerns.